
|Videos|December 15, 2022
Screening for Brain Metastases in HER2+ Breast Cancer
Andrew Brenner, MD, explains when physicians should screen patients with HER2+ breast cancer for brain metastases.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Olomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer
2
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
3
Why CAR T-Cell Therapy Should Precede Bispecifics in Multiple Myeloma
4
Epcoritamab Combo Shows Sustained Remissions in Follicular Lymphoma
5























































